Congenital scoliosis, a lateral curvature of the spine caused by vertebral defects, occurs in approximately 1 in 1,000 live births. Here we demonstrate that haploinsufficiency of Notch signaling pathway genes in humans can cause this congenital abnormality. We also show that in a mouse model, the combination of this genetic risk factor with an environmental condition (short-term gestational hypoxia) significantly increases the penetrance and severity of vertebral defects. We demonstrate that hypoxia disrupts FGF signaling, leading to a temporary failure of embryonic somitogenesis. Our results potentially provide a mechanism for the genesis of a host of common sporadic congenital abnormalities through gene-environment interaction.
INTRODUCTION
Around 1 in 1,000 live births have congenital scoliosis (CS) (Hedequist and Emans, 2007) . This is clinically defined as a lateral curvature of the spine exceeding 10 degrees and caused by structural vertebral defects. It may occur in isolation or as a component of a syndrome along with congenital defects in other organ systems. CS is distinct from rarer syndromes such as spondylocostal dysostosis (SCD) and spondylothoracic dysostosis (STD) that are characterized by multiple severe contiguous vertebral defects, often affecting the entire spine (Giampietro et al., 2009) . Although many SCD and STD cases are simple recessive monogenic traits , it is unlikely that CS has a simple genetic etiology. Instead, there is likely a strong environmental influence on its development. In particular, maternal exposure to a wide range of environmental conditions early in gestation has been implicated in the generation of vertebral defects (Alexander and Tuan, 2010) . Such defects are not usually the result of defective bone formation, rather they arise from the failure of an earlier developmental process. The axial skeleton is derived from the presomitic mesoderm (PSM). This is composed of two populations of cells on either side of the neural tube in the caudal part of the embryo. Blocks of cells (somites) separate from the rostral end of this tissue at regular intervals ($2 hr in mouse and 4-6 hr in human [Tam, 1981; William et al., 2007] ), in a process called somitogenesis. Somites are the precursors of not only the vertebrae but also skeletal muscle, tendons, ligaments, and dorsal dermis (Christ et al., 2007) .
Somitogenesis requires the interaction of two components, referred to as the clock and wavefront (Pourquié , 2011) . The PSM contains opposing gradients of FGF and Wnt signaling (caudal-rostral) and retinoic acid signaling (rostral-caudal) . Specific thresholds of FGF and Wnt signaling set the position of a determination front (the wavefront); caudal to this point cells are maintained in an undifferentiated state, whereas rostrally cells become competent to form somites. At the same time, PSM cells express a number of genes in an oscillatory pattern (the clock), and bands of expression appear to move in a caudalto-rostral direction. Each cycle of expression has the same periodicity as somite formation. When the determination front reaches a group of cells in the appropriate phase of oscillatory gene expression, a somite can form. Disruption of somitogenesis by either genetic or pharmacological means in a variety of vertebrates results in vertebral defects (Gibb et al., 2010) . For example, in humans, homozygous mutation of any one of four genes causes SCD, and in mouse targeted deletion of the same genes leads to a similar phenotype .
Here we present evidence for a genetic etiology for CS and identify deleterious mutations in HES7 and MESP2 in individuals with CS from two unrelated families. These mutations are dominant, but weakly penetrant. We confirm in mice that haploinsufficiency of Hes7 can cause vertebral defects, resulting in a CS-like phenotype with incomplete penetrance. We also demonstrate an environmental influence on CS in mice, whereby exposure of embryos to an atmosphere that induces a very low rate of vertebral defects in wild-type mice (mild hypoxia) not only induces a CS-like phenotype in some Mesp2 +/À embryos but also dramatically increases the severity and penetrance of vertebral defects in Hes7 +/À embryos. This is also true for two other components of the Notch signaling pathway, Dll1 and Notch1. In addition, we demonstrate a molecular mechanism for this phenomenon and show that hypoxic exposure causes a temporary downregulation of FGF and Wnt signaling in the PSM and also disrupts cyclical Notch signaling, ultimately interfering with somitogenesis. The primary defect is likely to be the interruption of FGF signaling. Our results have broad implications and may provide a mechanism for the genesis of a wide range of sporadic human congenital defects through gene-environment interactions.
RESULTS

Haploinsufficiency of HES7 or MESP2 Is Associated with Congenital Scoliosis in Humans
We and others have previously identified that homozygous mutations in four genes can cause SCD (DLL3, MESP2, LFNG, and HES7) . We hypothesized that the isolated vertebral defects of CS might result from heterozygous mutation of any one of the four genes known to cause the severe vertebral defects of SCD in the homozygous state. This was supported by the observation that 43% of adult Hes7 +/À mice have kinked tails (Bessho et al., 2001 ), a phenotype likely to be the result of one or more malformed tail vertebrae (Nomura- Kitabayashi et al., 2002) . Further support was provided by the observation that two unrelated individuals with heterozygous nonsynonymous SNPs in DLL3 had CS (Bulman et al., 2000; Maisenbacher et al., 2005) . We screened 79 cases of CS for coding region and splice-site mutations in each of the previously identified SCD-causing genes. We found two probands that were heterozygous for nonsynonymous coding SNPs, one each in HES7 (family A) and MESP2 (family B). A brief summary of each family is given below, and more detail is provided in the supplemental material.
In family A, the proband presented with a scoliotic curve caused by complex multiple vertebral and rib defects from lower cervical levels to T10 ( Figure 1A ). Sequencing revealed that this individual was heterozygous for a novel coding SNP in HES7 (c.NM_001165967.1:424G>T), resulting in the amino acid substitution D142Y (p.NP_001159439.1:D142Y). This SNP was not present in dbSNP or 1000 Genomes databases or in 107 ethnically-matched control samples. This change significantly reduced the repressive activity of HES7 protein in functional assays in vitro (Figure S1A available online) but did not alter the expression level of the protein ( Figure S1C ). The mother also carried the D142Y mutation ( Figure 1F ) but did not show any spinal defects externally or report a history of back pain; however, due to ethical constraints, we could not obtain an axial radiograph for analysis.
In family B, the proband had vertebral defects in T3 and at the thoraco-lumbar junction, rib anomalies, and fusion of the posterior elements of C2 and C3 ( Figures 1B-1D ). Sequencing revealed that this individual was heterozygous for a novel coding SNP in MESP2 (c.305A>C), resulting in the amino acid substitution H102P (p.H102P). This SNP was not present in dbSNP or 1000 Genomes databases or in 97 ethnically-matched control samples. This change completely inactivated MESP2 in an in vitro functional assay ( Figure S1B ) but did not affect the expression level of the protein ( Figure S1C ). We screened the proband's three siblings, mother, and maternal grandparents and determined that two siblings, the mother and maternal grandfather, carried the same mutation ( Figure 1G ). Radiographic analysis revealed that the mother had bony fusion of the vertebral bodies and posterior elements of C2 and C3 (Figure 1E) . However, neither of the carrier siblings had abnormal vertebral morphology, indicating partial penetrance. The maternal grandfather was not available for examination. Thus a deleterious allele of HES7 or MESP2 occurs in association with CS in humans.
Haploinsufficiency of Hes7 Causes Congenital Scoliosis with Incomplete Penetrance in Mice
The above evidence supports our hypothesis. However, it is also possible that the CS-affected individuals possessed undetected mutations at second loci involved in somitogenesis. To determine whether these heterozygous mutations alone were sufficient to cause a CS-like phenotype, we examined mouse lines carrying null alleles of Hes7 or Mesp2. As noted above, 43% of Hes7 +/À adult mice have kinked tails but the spinal morphology of adults or embryos has not been described. We collected wild-type and Hes7 +/À embryos at embryonic day (E) 14.5 and examined the developing axial skeleton. To aid classification of the extent and severity of defects, we separated embryos into four groups: no defects and mild, moderate and severe defects ( Figures S2A-S2D ). Sixteen out of thirty Hes7 +/À embryos had some type of vertebral defect, whereas 33/34 wild-type littermates were normal (Figures 2A and 3A ). Defects were predominantly located in vertebrae T7-L4 ( Figure S3A , yellow bars Figure 3B ). Thus in mice, loss of one allele of Hes7 (but not Mesp2) is sufficient to cause vertebral defects in 50% of cases.
Gene-Environment Interaction Increases the Frequency and Severity of Vertebral Defects in Mice
Because heterozygous mutation of Mesp2 did not lead to vertebral defects in mouse, despite the association with CS in humans, we hypothesized that there might be an additional factor required to trigger CS in such cases. This might be environmental because studies beginning in the early 19 th century have shown that depriving the developing vertebrate embryo of oxygen can cause gross structural abnormalities (Geoffroy Saint Hilaire, 1820). More systematic studies in the mid-20 th century indicated that a range of defects, including malformation of the heart, limb, palate, and vertebral column, are inducible by this method (Ingalls et al., 1952) . Importantly, vertebral defects very similar to those seen in Hes7 +/À mouse embryos can be induced. Such observations may be applicable to human pregnancy because intrauterine hypoxia can be caused by many environmental factors (Hutter et al., 2010) . We therefore investigated whether exposure of Mesp2 +/À mouse embryos to hypoxia in utero would induce CS. First we established a protocol using wild-type C57BL/6J mice. Short-term hypoxia at E9.5 has a maximal effect on vertebral formation (Ingalls and Curley, 1957) . We exposed pregnant mice at E9.5 to 5.5% atmospheric oxygen for 8 hr. This is the lowest oxygen level that mice can tolerate and corresponds to levels used previously. After exposure, we returned dams to normoxia and harvested embryos at E14.5 for analysis of vertebral formation. We detected vertebral defects in 20/22 embryos, with 15 of these being moderate or severe ( Figures S2C and  S2D ). The defects were distributed symmetrically around a peak at L2 ( Figure S3B , red bars).
We next established an oxygen dose-response ( Figure S2E ). Exposure of dams to R8.5% oxygen produced no vertebral defects, whereas exposure to 8% induced a small number of mild defects (4/26). At 7.5%, 1/29 embryos had severe defects, 7 moderate and 5 mild; and at 6.5% nearly all embryos had moderate or severe defects (20/24 plus 1 mild defect). Defects were distributed along the rostral-caudal axis, similarly to those induced by 5.5% ( Figure S3B ). We conclude that there is a sharp threshold in the sensitivity of somitogenesis to hypoxia and that treatment with 8% oxygen is near this threshold. We therefore used this level of exposure to test our hypothesis.
We mated Mesp2 +/À males to C57BL/6J females to generate litters with both wild-type and heterozygous embryos. We exposed pregnant females to 8% oxygen (mild hypoxia) for 8 hr at E9.5 and then returned them to normoxia before analysis of embryonic vertebral morphology at E14.5 as before. Use of wild-type mothers removed any potential differences due to genotype in the maternal response to treatment. We allowed control litters from the same cross to develop in normoxia throughout gestation. Six out of twenty-six wild-type embryos exposed to mild hypoxia showed mild vertebral defects and 1/26 had a moderate defect ( Figures 2D and 3B ). By contrast, hypoxia induced a significantly higher rate and severity of defects in Mesp2 +/À embryos (6 mild, 8 moderate, and 2 severe defects out of 28 embryos; Figure 3B ). These were in the same rostralcaudal position as those induced in wild-type embryos at lower oxygen levels ( Figure S3C , red bars). Interestingly, some wildtype (4/26) and Mesp2 +/À (10/27) embryos had extra ribs arising from L1, suggesting a homeotic transformation of this vertebra. This evidence for a gene-environment interaction in the Mesp2 strain lead us to speculate that the variable penetrance and severity of defects seen in Hes7 +/À mouse embryos, and in family A, might be due to similar interactions. We therefore tested Hes7 +/À embryos in the same system and observed a dramatic increase in the severity and penetrance of vertebral defects (Figures 3A and Figure S3A , red bars). Typically the severe phenotype involved more extensive abnormalities than observed in wild-type embryos with any level of oxygen treatment; with up to eight contiguous hemi-, fused, or split vertebral bodies, with concomitant bilateral loss of pedicles, resulting in severe scoliosis ( Figure 2B ).
To examine whether these results indicated a broader interaction between hypoxia and Notch signaling, we extended our analysis to three other Notch pathway genes required for somitogenesis (Dll3, Dll1, and Notch1). Vertebral defects were not detected in normoxic Dll3 +/À embryos, and hypoxia did not induce a significantly higher rate and severity of vertebral defects in Dll3 +/À embryos compared to controls ( Figure 3C ). Next we examined Dll1. Previously, 10% of Dll1 LacZ/+ mice were described as having minor vertebral defects (Cordes et al., 2004) . By contrast, we observed that mice heterozygous for a different null allele of Dll1 (Dll1 tm1.1Mjo ) in normoxia had complete penetrance of mild to moderate vertebral defects ( Figures 2E and  3D ), predominantly cervically ( Figure S3D , yellow bars). This discrepancy may have been due to differences between the two alleles or their genetic backgrounds. Furthermore, shortterm mild hypoxia (8% oxygen) resulted in a substantial increase in the severity of defects in Dll1 +/À embryos ( Figures 2F and 3D ). This was due to the induction of moderate to severe defects in T11-L5, and there was little change in the frequency or severity of cervical abnormalities ( Figure S3D , red bars). Lastly, in Notch1 +/À embryos we observed that shortterm mild hypoxia induced a significantly higher rate and severity of vertebral defects compared to controls ( Figures 2H and 3E ), albeit at a lower frequency than for Hes7 or Dll1. These defects were also predominantly present in the caudal thoracic to lumbar region ( Figure S3E , red bars). Thus mild hypoxia increased the incidence and severity of vertebral defects in genetically-susceptible mice.
Hypoxia Disrupts Cyclical Notch1 Signaling in the PSM
We next investigated the molecular mechanism for our observations. There was a clear relationship between the timing of the hypoxic treatment and the axial position of the vertebral defects (see Experimental Procedures). We inferred that short-term gestational hypoxia affects the initial patterning of presumptive somites in the PSM, rather than the segmentation process or the subsequent differentiation of the somite (Supplemental Information and Figure S2F ). Somitogenesis is controlled by the intersection of four signaling pathways: Notch, Wnt, FGF, and retinoic acid (Pourquié , 2011) . Our results show that hypoxia impacts on four genes of the Notch signaling pathway. Therefore, we first examined the levels and pattern of Notch1 signaling in the PSM of treated and untreated embryos using whole-mount immunofluorescence with an antibody specific to S3-cleaved (activated) Notch1. To maximize our ability to identify the molecular mechanism responsible for the vertebral defects, we exposed embryos to 5.5% oxygen for 8 hr and then dissected and fixed immediately. At this level of exposure, 90% of embryos had vertebral defects ( Figure S2E ). Notch1 signaling is activated in a cyclical manner in the caudal PSM (Huppert et al., 2005; Morimoto et al., 2005) , with an additional stripe of expression in the rostral PSM (in the caudal half of the forming somite, S0; Chapman et al., 2011) . Embryo fixation will stop the oscillation at a random point in the cycle and by convention any particular embryo can be The vertebral morphology of E14.5 mouse embryos was assessed by Alcian blue staining and divided into four categories. The graphs represent the percentage of embryos in each category. (A) Hes7, (B) Mesp2, (C) Dll3, (D) Dll1, and (E) Notch1. Data was tested for statistical significance as described in the experimental procedures. ns is an abbreviation for not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S3 .
described as being in one of three phases (Pourquié and Tam, 2001) . Appropriately, we examined 36 control embryos and found 10 in phase I, 12 in phase II, and 14 in phase III ( Figures S4A-S4C ). As expected, cleaved Notch1 was nuclear in all embryos ( Figure S4I 0 ). By contrast, we observed that 25/31 hypoxiatreated embryos displayed a unique pattern in which cleaved Notch1 was present throughout the PSM (Figure 4F ), an incidence that correlates well with the incidence of vertebral defects observed at E14.5 ( Figure S2E ). This pattern was similar to phase I but instead of a clear gap of nonsignaling cells between the rostral stripe and the caudal domain, cleaved Notch1 was clearly present in all cells between the two domains ( Figures  4A and 4F , white arrows, and Figures 4B and 4G , magnified views). Thus hypoxia disrupts cyclical activation of Notch1 signaling in the PSM. Despite this disruption in pattern, cleaved Notch1 was correctly localized to the nucleus in treated embryos ( Figure S4P 0 ). Total or partial disruption of Notch1 signaling, or perturbation of its cyclical activation, causes segmentation defects (Ferjentsik et al., 2009; Morimoto et al., 2005; Shifley et al., 2008) ; therefore, it is likely that the lack of cycling of cleaved Notch1 in treated embryos directly results in the observed segmentation defects.
Disruption of Cyclical Notch1 Signaling Is Caused by Loss of Negative Feedback Loops
To determine how Notch1 signaling was being altered, we analyzed protein levels of the Notch1 receptor and two of its ligands, Dll1 and Dll3. Notch1 protein is normally expressed in the rostral PSM, spanning S0 and S1 . We observed no difference in Notch1 protein expression levels or domain in control (n = 7) and treated (n = 9) embryos ( Figures  4C and 4H ). Costaining confirmed Notch1 signaling was altered in the treated embryos ( Figures 4A and 4F ). Dll1 protein is normally expressed throughout the PSM, and there is an abrupt boundary directly adjacent to the most rostral stripe of Notch1 signaling . We found the same expression levels and pattern in both controls (n = 4) and treated (n = 5) embryos ( Figures 4K and 4P) . Costaining of treated embryos confirmed Notch1 signaling was altered ( Figure 4M,R) . The same embryos were costained for Dll3 and showed no change in the domain or level of expression of this protein (Figures 4L Figures S4N and  S4Z , respectively]). We confirmed the results for Dll1 and Dll3 at the transcript level ( Figures 5A-5D , n = 4/5 and 5/5 were normal, respectively; in both cases five controls were normal). This suggests that the change in Notch1 signaling observed in treated embryos was not due to altered ligand or receptor expression or protein localization.
The cycling of cleaved Notch1 is controlled by negative feedback loops involving the glycosyltransferase Lfng and the transcription factors Hes7 and Mesp2 (Morimoto et al., 2005; Pourquié , 2011) . We therefore examined transcripts of these genes in treated embryos. Lfng transcripts are normally expressed in a cyclical fashion in the PSM (Forsberg et al., 1998 ). Fittingly we observed that Lfng was strongly expressed in 20 controls, and these were equally distributed between the three phases ( Figure 5E and Figures S5A-S5C ). By contrast, Lfng transcripts were absent or reduced in 11/12 treated embryos ( Figure 5F ).
Hes7 transcripts are also expressed cyclically in the PSM but in a slightly different pattern to cleaved Notch1 and Lfng (Bessho et al., 2003) . We observed 18 control embryos with robust Hes7 expression, and these were equally distributed between the three phases ( Figure 5G and Figures S5D-S5F ). By contrast, 9/13 treated embryos had absent or reduced expression ( Figure 5H ). Expression levels were too faint to determine whether cycling was occurring. Fittingly, Hes7 protein was absent or strongly reduced in 7/10 treated embryos ( Figures 4U and 4Y , nine controls were normal). Costaining for cleaved Notch1 showed Notch1 signaling was altered only in those treated embryos that had absent or reduced Hes7 ( Figure 4Z ).
Mesp2 is most often expressed in a single stripe in the rostral PSM, with a progressive narrowing of expression domain as the embryo passes through phases I to III (Takahashi et al., 2000) . Mesp2 expression in 18 control embryos was equally distributed among the three phases ( Figures 5I and Figures S5G-S5I ) but 9/11 treated embryos had absent or reduced expression (Figure 5J) . In all cases where expression could be detected, the stripe was broad (similar to phase I). The reduction of Mesp2 expression in treated embryos was unexpected, because Mesp2 is a direct target of Notch signaling (Yasuhiko et al., 2006) . The transcription factor Tbx6 is also required for Mesp2 expression (Yasuhiko et al., 2006) , and we found that transcript levels of Tbx6 were reduced in 4/5 treated embryos ( Figures  5K and 5L , five controls normal). Thus inhibitors of Notch1 activation are lost in the PSM.
Mild Hypoxic Exposure Does Not Alter Cyclical Expression of Notch1 Regulator Genes Exposure of Hes7
+/À embryos to mild hypoxia induces more severe vertebral defects than those induced in Mesp2
embryos. This could result from a difference in the effects of mild hypoxia on the expression of these genes. We therefore examined Hes7 and Mesp2 transcript levels and localization in wild-type embryos exposed to 8% oxygen for 8 hr. In both cases normal cycling was apparent (Figures S5D 0 -S5F 0 , and S5G 0 -S5I 0 , respectively). This was also true of Lfng (Figures S5A 0 -S5C 0 ). Thus the differences in the severity of vertebral defects induced in Hes7 +/À and Mesp2 +/À embryos are unlikely to be due to differences in the susceptibility of these genes to perturbation of their expression by mild hypoxia. 
Hypoxia Abolishes FGF Signaling in the PSM
The alterations in expression level and pattern of Notch pathway components and target genes are similar to those described for embryos homozygous for the hypomorphic Wnt3a allele vestigial tail (Aulehla et al., 2003) and also to embryos with PSM-specific interruption of FGF signaling (Naiche et al., 2011; Niwa et al., 2007; Oginuma et al., 2008; Wahl et al., 2007) . This suggests that the disruption of Notch1 signaling might be caused by perturbation of Wnt and/or FGF signaling. We found reduced Wnt3a transcripts in 4/5 treated embryos ( Figures 6A and 6B , six controls normal) and concomitantly, strongly reduced levels of Wnt signaling in 8/8 treated embryos, as detected by LacZ transcript levels in embryos of the BATGal reporter mouse line ( Figures 6C and 6D, eight controls normal) . In the PSM, a gradient of FGF signaling extends from caudal (high) to rostral (low). This is driven by a gradient of the Fgf8 ligand signaling through the FgfR1 receptor (Dubrulle and Pourquié , 2004; Wahl et al., 2007) . Fgf8 and FgfR1 transcripts were unaltered in treated embryos ( Figures 6E-6H , n = 6/6 in both cases, seven and six controls normal, respectively), but transcripts of direct target genes of FGF signaling (Spry4 and Dusp6) were reduced ( Figures  6I and 6J and data not shown, n = 11/14 and 8/8 respectively; 12 and 8 untreated embryos were normal). This suggests that the hypoxic treatment was disrupting FGF signaling upstream of the transcriptional regulation of these target genes.
Although FGF signaling can occur through more than one signal transduction pathway (Pownall and Isaacs, 2010) , the key pathway in the PSM is ERK/MAPK (Sawada et al., 2001) . In mouse, the FGF effector double-phosphorylated ERK (dpERK) is present as a gradient in the PSM (caudal high-rostral low) that cyclically expands rostrally to S-2 (Niwa et al., 2011; Figures S6A-S6C) . In addition, during phase III a sharp band of expression is present in the forming somite (S0), corresponding to the location of FgfR1 transcripts ( Figure 6G ). We detected dpERK levels in embryos using immunofluoresence. Of 11 control embryos, 4 were in phase I ( Figure S6A ), 4 in phase II ( Figure S6B ) and 3 in phase III ( Figures 7A and Figure S6C ). By contrast, we found dpERK expression absent or reduced in 12/13 treated embryos, and no rostral band was ever detected ( Figure 7D ). Costaining with Notch1 protein confirmed that the immunofluoresence was successful (Figures 7B and 7E ). Thus hypoxia inhibits ERK/MAPK and direct target genes of FGF signaling.
DISCUSSION
The phenomenon that gestational hypoxia disrupts embryonic development has been known for over 190 years (Geoffroy Saint Hilaire, 1820). Here we have identified one molecular mechanism by which this occurs: disruption of somitogenesis and its key signal transduction pathways. We propose a model in which the primary effect of short-term hypoxia is disruption of FGF signaling and the perturbation of Wnt and Notch1 signaling is a secondary consequence. Our reasoning is two-fold. First, Wnt signaling in the PSM requires the ligand Wnt3a (Aulehla et al., 2003) . FGF signaling is required for Wnt3a transcription (Naiche et al., 2011) , and pharmacological inhibition of FGF signaling in cultured explants inhibits the expression of a direct target of Wnt signaling in the PSM (Axin2, Wahl et al., 2007) , although there is still some speculation on how these pathways interact in somitogenesis (Aulehla et al., 2008) . Wnt3a transcripts were substantially reduced in response to hypoxic treatment ( Figure 6B ), whereas transcript levels of other secreted or cell surface proteins (such as Fgf8, Dll1, and Notch1) were unaffected. Thus it is probable that the reduction in Wnt3a transcription and Wnt signaling is due to the disruption of FGF signaling. Second, FGF signaling through MAPK/ERK is required for the initiation of Hes7 expression in the caudal PSM, as well as for maintenance of Hes7 oscillation throughout the PSM (Niwa et al., 2007) . Hes7 oscillation in turn is required for Notch1 cycling (Niwa et al., 2011) . Thus the cessation of Notch1 cycling in treated embryos is likely due to the reduction of Hes7 levels, and this also results from interrupted FGF signaling. We recognize that certain observations do not easily fit within this simple model. First, Lfng expression is activated by Notch signaling (Morales et al., 2002) , and its oscillatory pattern is also controlled by Hes7 protein (Niwa et al., 2007) . Our model predicts that hypoxia will result in a loss of Lfng cycling because Hes7 protein levels are reduced or lost, and indeed this is observed. However, because cleaved Notch1 is present throughout the PSM, noncycling Lfng should be expressed throughout the PSM. Instead we see a reduction or loss of expression ( Figure 5F ), implying that other factors, perhaps FGF signaling itself, are also required for Lfng expression levels. Second, Mesp2 transcription is normally repressed by FGF signaling (Oginuma et al., 2008) and activated by Notch signaling (Yasuhiko et al., 2006) . Our model would predict an increase in Mesp2 levels in treated embryos. The fact that we see the opposite ( Figure 5J ) can be explained by reduced Tbx6 expression ( Figure 5L ), which is also required for Mesp2 transcription (Yasuhiko et al., 2006) . How might hypoxia be acting to interrupt signaling? Cells exposed to lowered oxygen levels can respond in different ways. Much research has focused on long-lasting epigenetic changes triggered by environmental conditions (Daxinger and Whitelaw, 2010) . However, we can rule out epigenetic effects in our system because somite formation returns to normal shortly after removal of the hypoxic insult. Hypoxia can also disrupt protein folding, and the resultant increase in unfolded proteins in the endoplasmic reticulum (ER) causes ER stress and activation of the unfolded protein response (UPR). This results in a general reduction of translation and ER transport and an increase in expression of chaperone proteins, and if these two functions do not alleviate the ER stress, apoptosis is triggered (Wouters and Koritzinsky, 2008) . Activation of UPR might provide an explanation for the interruption of FGF and Wnt signaling because exposure of cells in culture to anoxia for 24 hr blocks processing and secretion of Wnt3a (Verras et al., 2008) . We were unable to detect Wnt3a or Fgf8 protein in wildtype embryos to determine whether this also occurs in vivo under our milder hypoxic insult.
Our experimental model of in utero hypoxia demonstrates that an environmental insult can affect penetrance and severity of the CS phenotype in genetically-susceptible mice, and this offers an explanation for the phenotypic variation in our families. In addition, our discovery that mouse embryos carrying null mutations in Dll1 and Notch1 also show higher rates of vertebral defects after short-term hypoxic treatment suggests that these genes are excellent candidates for further sequencing of CS patient DNA. It has been known for almost a century that both Notch and Delta are haploinsufficient in Drosophila melanogaster (Bellen et al., 2010) ; in humans haploinsufficiency of JAG1 or NOTCH2 can cause Alagille syndrome (Turnpenny and Ellard, 2012) , and NOTCH1 haploinsufficiency is associated with aortic valve disease (Garg, 2006) . Thus it is perhaps not surprising that some human individuals and mouse embryos heterozygous for deleterious or null mutations of Notch pathway genes should show vertebral defects. There are two opposing models of how changes in Notch signaling can affect complex systems. First, studies of lateral inhibition in cell culture suggest that in individual cells, Notch signaling acts as a switch between mutually exclusive sending or receiving signaling states and that this is very sensitive to the relative levels of Notch and Delta proteins in these cells (Sprinzak et al., 2010) . This model suggests that perturbation of Notch signaling in our system by either genetic or environmental factors triggers an inappropriate switch in cell fate and that action of both factors together may increase the likelihood of this. Alternatively, a model of zebrafish somitogenesis suggests that Notch signaling does not act as an on/off switch, but instead transmits a smoothly graded signal (Riedel-Kruse et al., 2007) . This model predicts that the genetic reduction of Notch signaling in our system will shift the threshhold of sensitivity to hypoxia, resulting in disruption of somitogenesis at a higher oxygen level. Our current data does not appear to favor either model. We observed subtle differences in the phenotypes induced for each gene in mouse embryos (Figure 2 ). These might serve as useful clinical indicators of which gene is involved. In addition, our experimental system could be used as a method of screening other somitogenesis genes for their potential role in causing CS. Despite the previous identification of CS patients with heterozygous mutations in DLL3 (Bulman et al., 2000; Maisenbacher et al., 2005) , we did not observe an interaction between hypoxic treatment and the Dll3 null allele in mice, suggesting that in this case, if the trigger is environmental, it is something other than hypoxia. The Dll3 mouse model could be used to screen a range of environmental influences to determine such a trigger. Importantly, our experimental system could also be used to screen therapeutic strategies to reduce the risks of vertebral defects.
Although gene-environment interactions have been known for a long time and are speculated to underlie the sporadic nature of a host of human diseases, the evidence of the mechanisms have largely proved elusive. One notable exception is the role of viral infection of genetically susceptible individuals in Crohn's disease (Cadwell et al., 2010) . Therefore, our discovery that the vertebral defects induced by hypoxia are likely to be due to an interruption of FGF signaling is an important addition to this field. In addition to its role in somitogenesis, Fgf8 has key roles in many other processes during embryogenesis including brain (Meyers et al., 1998) , heart (Frank et al., 2002) , limb (Lewandoski et al., 2000; Moon and Capecchi, 2000) , and craniofacial development (Meyers et al., 1998) . It is particularly intriguing that several nonrandom associations of congenital abnormalities, including VATER/VACTERL (OMIM 192350) and MURCS (OMIM 601076), affect multiple organs that require Fgf8 for their formation. It is considered by some that such disorders might be related to vascular disruption at a critical developmental phase. Clearly such disruption could have hypoxic implications. In addition, although usually described as sporadic, evidence is now emerging of a heritable component to VACTERL (Solomon et al., 2010) . This raises the possibility that interactions between an environmentallyinduced reduction of Fgf8 signaling, coupled with a genetic deficit, play an important role in the etiology of a wide range of sporadic human congenital defects.
EXPERIMENTAL PROCEDURES
Informed consent was obtained for all subjects, and approval for patient studies was granted by the St Vincent's Hospital Human Research Ethics Committee, Sydney, Australia (approval number H05/057); Arizona State University, Tempe, AZ, USA (institutional review board protocol number 0604000773); the Children's Hospital of Philadelphia, Philadelphia, USA (IRB Protocol number 01-002451_CR1); and the Hospital for Sick Children, Toronto, Canada (IRB Protocol number 1000013472).
Animal Experiments
We performed animal experiments in accordance with the relevant institutional and national guidelines and regulations with the approval of the Garvan Institute of Medical Research/St Vincent's Animal Experimentation Ethics Committee, Sydney, Australia (approval number 09/33). We exposed pregnant mice to lowered oxygen levels at normal atmospheric pressure using an anesthesia induction chamber (Advanced Anaesthesia Specialists) connected to a nitrogen cylinder via a ProOx P110 oxygen controller (BioSpherix). We calibrated the oxygen sensor prior to each experiment, and setup the controller according to the manufacturer's instructions to provide a constant oxygen level ±0.2%. We reduced the oxygen level to the target level over a 20 min period and at the end of the exposure either removed mice immediately for sacrifice and embryo collection or gradually returned them to normoxia over a 20 min period for embryo harvest at a later date.
Immunofluoresence and Immunoblots
We performed whole-mount immunofluorescence on fixed embryos as previously described (Geffers et al., 2007) . Immunoblots were performed by standard methods with detection using a Li-Cor Odyssey Infrared Imaging System. Antibodies are listed in the Extended Experimental Procedures.
RNA In Situ Hybridization and Histology
We performed whole-mount RNA in situ hybridization as described previously (Dunwoodie et al., 1997) , with probes listed in the Extended Experimental Procedures. We performed Alcian blue 8GX cartilage staining as described (Jegalian and De Robertis, 1992) , except that embryos were stained for 3-6 days at room temperature. We photographed embryos after clearing in 2:l benzyl benzoate:benzyl alcohol.
Image Manipulation
In order to allow easy comparison of protein and transcript expression patterns in the PSM between different embryos, the left-right orientation of some images was reversed. This does not misrepresent these data because there is no difference in expression of these proteins and transcripts between the left-and right-hand sides of these embryos. The reversed panels are: Figures  4A-4D , Figures 5E and 5F; and Figures 7D and 7E; and Figures S4A and S4C and Figures S5A-S5C .
Determination of the Developmental Process Disrupted by Hypoxia
Fate mapping experiments show that each somite contributes to two adjacent vertebra, with cells from the caudal portion of one somite and cells from the rostral portion of the next somite combining to form a complete vertebra, a process called resegmentation (Bagnall et al., 1988; Huang et al., 1996) . The relationship between somite number and the vertebrae that it will contribute toward is invariant. For example, in mouse the tenth vertebrae (T3) always forms from somites 14 and 15 (Burke et al., 1995) . These facts enabled us to infer which developmental process was being disrupted by the hypoxic insult. We determined the range of somites present during the hypoxic insult by counting somite numbers of wild-type embryos exposed for 8 hr at E9.5 and harvested immediately afterwards. Mean somite number of 267 embryos was 20.3 ± 4.1, with most embryos in the range of 13-27 somites ( Figure S2F ). At this developmental stage each somite takes about 2 hr to form in mouse (Tam, 1981) , and the PSM contains six prospective somites (S-1 to S-6; Tam, 1986; Tam et al., 1982) . Thus we estimate that in most embryos at E9.5 exposed to hypoxia for 8 hr: somites 0-15 had already formed; somites 16-20 were forming during exposure; and the precursors to somites 21-26 were present in the PSM. The peak of vertebral defects induced by such hypoxic treatment was in L2 (Figure S3B) , which is formed from somites 26/27. Thus the hypoxic insult was affecting early patterning events in the PSM, rather than somite segmentation or differentiation. Furthermore, in keeping with previous observations (Ingalls and Curley, 1957) , we did not observe defects caudal to S3 (formed from somites 33/34), suggesting that, when the short-term hypoxia was removed, somitogenesis recovered to normal.
Statistical Analyses
All statistical analyses were performed with Prism 5 for MacOSX (GraphPad Software Inc). Transfection assays were analyzed by one-way analysis of variance (ANOVA) and significance determined using Tukey's post hoc test. For analysis of the frequency and severity of induced vertebral defects, embryos were divided into four categories: no defect and mild, moderate, and severe. For Hes7, Mesp2, Dll3, and Notch1 mouse lines these categories were simplified into no defect and defect groups and tested using one-tailed Fisher's exact tests. Three comparisons were made for each experiment: wild-type control versus heterozygote control to test whether heterozygous embryos had a higher rate of defects than wild-types; heterozygote control versus heterozygote treated to test whether treatment increased the rate of defects in heterozygous embryos; and wild-type treated versus heterozygote treated to test whether heterozygous embryos had a higher rate of induced defects than wild-types. In the Dll1 line comparison of wild-type control versus heterozygote control and wild-type treated versus heterozygote treated were as above. Because there was complete penetrance of mild defects in heterozygous controls, to compare heterozygote control versus heterozygote treated, we grouped the embryos into no/mild defect and moderate/severe defect groups and tested using a one-tailed Fisher's exact test. Gene and protein expression patterns between wild-type and treated embryos were compared using one-tailed Fisher's exact tests. Exact p values for each analysis are in the Extended Experimental Procedures.
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